PDCD1 and melanoma: We also validated that these two T cell clones exhibited the same functional avidity for their cognate peptide (figure 4B) and that the reactivity of the PD-1-deficient clonotype was not impaired by the presence of PD-L1 on peptide-loaded T2 cell line or melanoma cells in vitro (figure 5).